News

The two Phase II, randomized, double-blind, placebo-controlled, dose-ranging studies enrolled a total of 157 patients and were conducted across 10 centers in the UK, Canada, and Australia. Multiple

The proposed indication in the marketing authorization application (MAA) is for the prevention of seasonal influenza. The MAA submission for live attenuated influenza vaccine (LAIV) is based on

Approved by the FDA under an investigational device exemption (IDE), the superficial femoral artery (SFA) study is a prospective, multicenter, single-arm trial planned to enroll 178 subjects at

The console powers Medtronic’s Midas Rex Legend EHS and Legend EHS Stylus drills, used primarily in spinal and cranial applications, and the Straightshot M4 Microdebrider, Visao, and Skeeter

Under the terms of the agreement, MicroDose will fund the development of prototypes based upon MicroDose’s inhaler platform and incorporating Nexus6’s SmartinhalerLive technology. MicroDose will receive an option

Under the terms of the agreement, S*BIO is eligible to receive up to $550 million in combined equity purchase, option and license fees, and development and sales milestone

Seppro depletion products enable scientists to measure more precisely the expression of protein biomarkers from a range of mammalian and plant biological samples. This acquisition covers current inventory,

Cerec AC is built on Sirona’s proprietary Cerec Bluecam technology and its automatic image capture system operates in such a way that entire quadrants can be scanned in

As a prerequisite for approval of Cimzia, the FDA has requested a new safety update with all clinical data including new data generated since the filing of the